These extracellular signals bind to specific receptors (e.g. IGF-1R and IL-6R), and then activate PI3K, which catalyzes the production of PI(3,4,5)P3, a key second messenger, that further mediates AKT activation and downstream signals in the MM pathophysiology [12]. Here, AKT1 is linked to Miyoshi myopathy.